GF Fund Management
RLAY icon

GF Fund Management’s Relay Therapeutics RLAY Stock Holding History

GF Fund Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$83.3K Buy
4,617
+378
+9% +$7.24K ﹤0.01% 349
2026
Q2 		$79.3K Buy
4,239
+363
+9% +$5.27K ﹤0.01% 354
2026
Q1 		$38.6K Buy
3,876
+470
+14% +$4.2K ﹤0.01% 430
2025
Q4 		$28.8K Sell
3,406
-303
-8% -$2.16K ﹤0.01% 465
2025
Q3 		$19.4K Sell
3,709
-577
-13% -$2.2K ﹤0.01% 491
2025
Q2 		$14.8K Hold
4,286
– – ﹤0.01% 528
2025
Q1 		$11.2K Buy
4,286
+771
+22% +$3.02K ﹤0.01% 552
2024
Q4 		$14.5K Buy
+3,515
New +$19.1K ﹤0.01% 502

Other funds holding RLAY

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
LF
Lighthouse Financial Largo, Florida $222M AUM 23.63% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Great Lakes Retirement
Great Lakes Retirement Sandusky, Ohio $1.14B AUM 34.02% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

GF Fund Management's RLAY Position: Q3 2026 in Review

GF Fund Management increased its Relay Therapeutics (RLAY) stake by 8.9% in Q3 2026, buying an estimated $7.24K and bringing the position to 4,617 shares worth $83.3K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

GF Fund Management first reported a position in RLAY in Q4 2024 and has held it in 8 quarters since. 29 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • GF Fund Management held 4,617 shares of Relay Therapeutics worth $83.3K as of Q3 2026.
  • GF Fund Management bought 378 Relay Therapeutics shares in Q3 2026, an estimated $7.24K.
  • Relay Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #349 holding.
  • GF Fund Management first reported a position in Relay Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 29 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.